Mycophenolate vs Azathioprin in Autoimmune Hepatitis
This study has been completed.
Information provided by:
First received: May 28, 2008
Last updated: May 29, 2008
Last verified: May 2008
A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.
Drug: Treatment with mycophenolat mofetil
Drug: Treatment with azathioprin
|Study Design:||Primary Purpose: Treatment|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Rigshospitalet, Denmark:
Contacts and Locations